SlidesetHIVINTEREST 2016Ebola to Lassa Fever: Leassons learnt | Ismail Adeshina Abdus-SalamView Slideset
SlidesetHIVINTEREST 2016Lessons learnt About the Ethics of Trial Conduct in Emergency Settings | Morenike Ukpong FolayanView Slideset
SlidesetHIVINTEREST 2016Lessons learnt About Good Participatory Practices in Prevention and Treatment Trials for HIV and for Emerging Pathogens | Lillian MutenguView Slideset
SlidesetHIVINTEREST 2016Lessons learnt from Ebola Therapeutic Trials and Survivor Cohort Studies | Daouda Sissoko, MDView Slideset
SlidesetHIVINTEREST 2016Progress on viral load monitoring, laboratory quality assurance, point of care | John Nkengasong, PhDView Slideset
SlidesetHIVINTEREST 2016Acquired Drug Resistance: Causes, Patterns, and Implications for SSA | Coumba Toure Kane, PharmD, PhDView Slideset
NPNicholas PatonMD, FRCPSlidesetHIVINTEREST 2016Evolving Treatment Paradigms: Relevance in Resource- Limited Settings | Nicholas Paton, MD, FRCPView Slideset
SlidesetHIVINTEREST 2016HIV Leadership and Financing Strategies for Countries in sub-Saharan Africa | Debrework Zewdie, PhDView Slideset
SlidesetHIVINTEREST 2016Progress in Hepatitis B and C in sub-Saharan Africa | Magloire Biwole Sida, MDView Slideset